<DOC>
	<DOCNO>NCT02704780</DOCNO>
	<brief_summary>This study evaluate intra umbilical vein injection 800 µg versus 400 µg misoprostol treatment retain placenta reduce need manual removal placenta general anaesthesia</brief_summary>
	<brief_title>Two Different Regimens Misoprostol Retained Placenta</brief_title>
	<detailed_description>The third stage labor may complicate retain placenta , may cause severe bleed infection , potentially fatal outcome . Manual removal placenta current standard management retain placenta usually require general regional anaesthesia hospital invasive procedure may lead bleeding , trauma infection . Intraumbilical injection uterotonic agent ( misoprostol ) easy , non invasive procedure . A randomized clinical trial require determine difference two dos misoprostol 400 versus 800 micro gram management retain placenta</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Placenta , Retained</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>woman singleton pregnancy , deliver vaginally 28 week gestation , prolonged third stage labor ( 30 minute ) despite active management , Haemodynamically stable accept participate trial multiple pregnancy , previous caesarean delivery , haemodynamically instability , severe anaemia ( haemoglobin concentration &lt; 8 g/dL ) , chorioamnionitis Refused participate trial</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Retained placenta</keyword>
	<keyword>Misoprostol</keyword>
	<keyword>double blind</keyword>
	<keyword>Randomization</keyword>
	<keyword>Haemorrhage</keyword>
</DOC>